Tumor efficacy of an oncolytic herpes simplex virus (NV1020) in patients with colorectal cancer metastatic to liver (mCRC)

Autor:	Daniel A. Geller, Axel Mescheder, Sunil K. Geevarghese, Daniel Y. Sze, Andrei Iagaru, R. S. Chari, Sanjiv S. Gambhir, Kenneth K. Tanabe, Tony R. Reid, John Nemunaitis
Rok vydání:	2008
Předmět:	Cancer Research VIRAL SYNDROME Genetically engineered Colorectal cancer business.industry viruses medicine.disease medicine.disease_cause Virology Oncolytic virus Herpes simplex virus Oncology medicine In patient business
Zdroj:	Journal of Clinical Oncology. 26:15014-15014
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2008.26.15_suppl.15014
Popis:	15014 Background: Dose-finding safety results are published for NV1020, a genetically engineered oncolytic Herpes simplex virus. Except for transient (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::25bdcbfb60a5269c6fac1a6c89fdfc96 https://doi.org/10.1200/jco.2008.26.15_suppl.15014 Zobrazit plný text záznamu